United States News All stories

CoreWeave (NASDAQ:CRWV) has expanded its global AI infrastructure by bringing most of its planned 22.5 megawatts of IT capacity online in Denmark and extending its network into the Middle East and Asia Pacific.

Cellectis (NASDAQ:CLLS) presented preclinical data for HEAL-101, a gene-editing candidate for severe hypertriglyceridemia, reporting approximately 90% mean editing in human liver cells.

Eli Lilly and Company (NYSE:LLY) declared a fourth-quarter 2026 cash dividend of $1.73 per share on its outstanding common stock, continuing shareholder distributions through the end of the year.

Gildan Activewear (NYSE:GIL) announced on October 26, 2026, that it completed the sale of HanesBrands Australia to BBFIT Investments Pte Ltd for approximately A$700 million, equivalent to US$490 million, paid entirely in cash at closing.

Cemex (NYSE:CX) reported third-quarter 2026 revenue of $4.59 billion, an increase of 8% from $4.25 billion a year earlier, surpassing Wall Street's consensus estimate of $4.45 billion.

MakeMyTrip Limited (NASDAQ:MMYT) reported fiscal second-quarter 2027 revenue of $235.2 million, an increase of 2.5% year over year, although the figure fell short of analysts' expectations of approximately $267.4 million to $269.1 million.

Citizens Community Bancorp (NASDAQ:CZWI) reported third-quarter 2026 net income of $5.4 million, compared with $1.1 million in the preceding quarter and $3.7 million a year earlier, while diluted earnings reached $0.56 per share.

XTEND AI Robotics (NYSE:XTND) announced preliminary, unaudited financial results projecting total revenue of $24.5 million to $26.5 million for the nine months ended September 30, 2026, exceeding its full-year 2025 revenue.

Medifast (NYSE:MED) reported third-quarter 2026 revenue of $72 million, a 19.4% decline from $89.4 million a year earlier, while its net loss widened to $17.5 million, or $1.57 per share, from $2.3 million, or $0.21 per share.

Lakeland Financial Corporation (NASDAQ:LKFN) reported record third-quarter 2026 net income of $28.9 million, an increase of 9% from $26.4 million a year earlier, while diluted earnings per share rose 11% to $1.14.

Sierra Bancorp (NASDAQ:BSRR) reported record third-quarter 2026 net income of $15.3 million, a 58% increase from $9.7 million a year earlier, while diluted earnings per share climbed 64% to $1.18 from $0.72.

S&P Global (NYSE:SPGI) has completed its acquisition of blockchain security company OpenZeppelin, expanding its digital asset risk assessment capabilities to cover the technology underlying tokenized financial products and decentralized finance.

Regeneron Pharmaceuticals (NASDAQ:REGN) announced a $270 million extension of its agreement with the Biomedical Advanced Research and Development Authority to supply additional doses of Inmazeb for U.S. preparedness against Ebola outbreaks.

Fate Therapeutics (NASDAQ:FATE) presented preliminary Phase 1 clinical results for FT819 showing renal responses in two evaluable patients with lupus nephritis, a serious kidney complication of systemic lupus erythematosus.

CAE (NASDAQ:CAE) has signed a definitive agreement to sell Flightscape, its airline operations software business, to aviation technology provider SITA for an enterprise value of US$500 million.

City Holding Company (NASDAQ:CHCO) reported third-quarter 2026 net income of $34.6 million and record diluted earnings of $2.43 per share, compared with $33.3 million and $2.35 per share in the second quarter.

Acumen Pharmaceuticals (NASDAQ:ABOS) reported a third-quarter 2026 net loss of $25.4 million, compared with $26.5 million a year earlier, as the biotechnology company prepares to release Phase 2 Alzheimer's disease trial results in November.

Verizon Communications (NYSE:VZ) reported third-quarter 2026 revenue of $34.3 billion, an increase of 1.5% year over year, while consolidated net income rose 5.2% to $5.3 billion and earnings per share increased 6.8% to $1.25.

HBT Financial (NASDAQ:HBT) reported third-quarter 2026 net income of $31.4 million, compared with $27.8 million in the preceding quarter, while diluted earnings per share increased to $0.86 from $0.76.

Enanta Pharmaceuticals (NASDAQ:ENTA) announced that the first patient has been dosed in RESOLVE, its global Phase 2b/3 clinical trial of investigational antiviral zelicapavir in adults at high risk of severe outcomes from respiratory syncytial virus infection.

Genmab A/S (NASDAQ:GMAB) reported updated Phase 2 results showing median overall survival of 28.2 months for petosemtamab combined with pembrolizumab in first-line treatment of recurrent or metastatic PD-L1-positive head and neck squamous cell carcinoma.

Alliance Resource Partners (NASDAQ:ARLP) reported third-quarter 2026 revenue of $603 million, an increase of 5.5% year over year, while net income attributable to the partnership climbed 46.8% to $139.6 million.

Bank of Hawai‘i Corporation (NYSE:BOH) reported third-quarter 2026 net income of $64.3 million, or $1.49 per diluted common share, compared with $63.8 million and $1.47 per share in the preceding quarter.

Ovintiv (NYSE:OVV) agreed to acquire Logan Energy in an all-cash transaction valued at approximately $890 million, including expected closing net debt, as the energy producer seeks to expand its Canadian asset portfolio.